Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Avalon GloboCare Corp. AVCO
$0.53
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
5258180.00000000
-
week52high
1.07
-
week52low
0.37
-
Revenue
1202169
-
P/E TTM
-3
-
Beta
0.80631100
-
EPS
-0.10200000
-
Last Dividend
0.00000000
-
Next Earnings Date
28 мар 2023 г. в 04:00
Описание компании
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Lu Wenzhao | A | 33192708 | 448718 | 05 авг 2022 г. |
| Lu Wenzhao | A | 32742989 | 4442989 | 25 июл 2022 г. |
| Lu Wenzhao | A | 32743990 | 4443990 | 25 июл 2022 г. |
| Lu Wenzhao | A | 32740390 | 4440390 | 18 июл 2022 г. |
| Lu Wenzhao | A | 28300000 | 2400000 | 21 дек 2021 г. |
| Lu Wenzhao | A | 2645161 | 645161 | 01 апр 2020 г. |
| Sanders Steven Andrew | A | 80000 | 80000 | 25 февр 2020 г. |
| Lu Yancen | A | 80000 | 80000 | 25 февр 2020 г. |
| Stilley William B. III | A | 80000 | 80000 | 25 февр 2020 г. |
| Li Meng | A | 300000 | 300000 | 25 февр 2020 г. |
Новостная лента
Avalon GloboCare to continue US-centric strategy with new proposed board composition ahead of Laboratory Services MSO acquisition
Proactive Investors
12 дек 2022 г. в 09:44
Avalon GloboCare Corp (NASDAQ:ALBT) has encouraged its shareholders to vote on a number of key proposals at its upcoming annual meeting to be held on December 29, 2022, at 11am Eastern Time. Shareholders can vote on a new proposed board composition to reflect the company's continued US focus and acquisition of Laboratory Services MSO LLC, Avalon said in a statement.
Avalon GloboCare to acquire majority interest in Laboratory Services MSO in 'transformative' deal worth $31M
Proactive Investors
08 ноя 2022 г. в 10:24
Avalon GloboCare Corp (NASDAQ:AVCO) is set to buy a 60% stake in Laboratory Services MSO as it expands its focus on lab testing and services in what it called a 'transformative' deal worth $31 million. California-headquartered Laboratory Services has completed over 600,000 tests since inception.
Stock Market Today: What Happened & 3 Penny Stocks To Watch Now
PennyStocks
29 сент 2022 г. в 21:15
What happened in the stock market today and Penny stocks to watch this week. The post Stock Market Today: What Happened & 3 Penny Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Avalon GloboCare gets notice of allowance from US patent office for QTY fusion platform
Proactive Investors
29 сент 2022 г. в 10:28
Avalon GloboCare Corp (NASDAQ:AVCO) has received a notice of allowance from the US Patent and Trademark Office (USPTO) related to its QTY fusion water-soluble receptor protein platform. The company's QTY code is a breakthrough technology that can turn difficult to work with water-insoluble transmembrane receptor proteins into water-soluble proteins, enabling their potential use in many clinical applications, including drug development, the company said.
Avalon GloboCare says its co-developed QTY code protein code technology featured in Chemical Reviews
Proactive Investors
08 авг 2022 г. в 10:46
Avalon GloboCare Corp (NASDAQ:AVCO) said that an article featuring its QTY protein code technology was published in Chemical Reviews, the official journal of the American Chemical Society. The publication, titled “Protein Design: From the Aspect of Water Solubility and Stability,” discusses the innovative QTY protein design code, which Avalon co-designed, as a novel platform to generate water-soluble proteins for a wide spectrum of biomedical applications.